Editor's Note In a move one expert calls “a complete U-turn,” the World Health Organization (WHO) has concluded that viruses transmit through primarily the air via inhalation of tiny suspended particles of saliva and mucus, KFF Health News reported on May 1. Until now, health authorities have relied on the…

Read More

Editor's Note Data published February 21 in The BMJ points to air pollution as a factor in increased hospital admissions for major heart diseases.  According to the Global Burden of Disease study, exposure to fine particulate matter (PM2.5) accounts for 7.6% of total mortality and 4.2% of disability-adjusted life years…

Read More

Editor's Note This spring, The Centers for Disease Control and Prevention (CDC) is expected to announce that individuals who test positive for COVID-19 no longer need to isolate if they’ve been fever-free for 24 hours and symptoms are mild or improving. Current guidelines, in place since 2021, recommend isolating for…

Read More

Editor's Note: Already shown to have a heightened risk of esophageal cancer, Asian Americans are also more likely to experience complications from esophagectomy, according to a study published January 4 in the American Journal of Surgery. The retrospective analysis, performed using ACS-NSQIP esophagectomy targeted database 2016–2021, compared 30-day postoperative outcomes…

Read More

Editor's Note The antibody shot Nirsevimab can protect infants from hospitalization from respiratory syncytial virus (RSV). The results from the new clinical trial were published December 28 in The New England Journal of Medicine. Affecting two of three children in their first year of life, RSV causes seasonal infection and,…

Read More

Editor's Note According to a new study from the University of Michigan, a surge in multiple respiratory viruses was associated with different pediatric acute care across emergency departments (EDs) across the state. The findings appeared in JAMA Network Open on December 7. The study used data from more than 2.7…

Read More

Editor’s note Moderna’s mRNA-based RSV vaccine is effective in preventing RSV-associated lower-respiratory tract disease in adults aged 60 an older, according to randomized phase II-III trial results published December 14 in The New England Journal of Medicine. Results also confirmed the safety of a single dose of the vaccine, researchers…

Read More

Editor's Note Hospitals in Fresno County, California are operating over capacity by 20% to 40% due to a sharp rise in respiratory diseases such as flu, COVID-19 and RSV, according to a December 18 press release from the Fresno County Department of Public Health. In addition to straining resources, the…

Read More

Editor's Note The Centers for Disease Control and Prevention (CDC) is sounding the alarm regarding low vaccination rates for COVID-19 and flu for all adults, as well as low RSV vaccination rates for adults 60 and older. According to the December 14 announcement, study data show anti-virals are also being…

Read More

Editor's Note A new vaccine for respiratory syncytial virus (RSV) has been found to be effective against a range of variants, according to an August 2023 Science Translational Medicine research article titled, "The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains." This research was…

Read More